Daily Oral Tenofovir and Emtricitabine-Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1-uninfected Men and Women: A Subgroup Analysis of a Randomized Trial

R L Ashley, J Militoni, F Lee, A Nahmias, L Corey, Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. Journal of Clinical Microbiology. ,vol. 26, pp. 662- 667 ,(1988) , 10.1128/JCM.26.4.662-667.1988

R. L. Prentice, L. A. Gloeckler, Regression Analysis of Grouped Survival Data with Application to Breast Cancer Data Biometrics. ,vol. 34, pp. 57- 67 ,(1978) , 10.2307/2529588

Séverin-Guy Mahiane, Camille Legeai, Dirk Taljaard, Aurélien Latouche, Adrian Puren, Aurélie Peillon, Jean Bretagnolle, Pascale Lissouba, Eugène-Patrice Ndong Nguéma, Elisabeth Gassiat, Bertran Auvert, Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa. AIDS. ,vol. 23, pp. 377- 383 ,(2009) , 10.1097/QAD.0B013E32831C5497

Kachit Choopanya, Michael Martin, Pravan Suntharasamai, Udomsak Sangkum, Philip A Mock, Manoj Leethochawalit, Sithisat Chiamwongpaet, Praphan Kitisin, Pitinan Natrujirote, Somyot Kittimunkong, Rutt Chuachoowong, Roman J Gvetadze, Janet M McNicholl, Lynn A Paxton, Marcel E Curlin, Craig W Hendrix, Suphak Vanichseni, None, Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet. ,vol. 381, pp. 2083- 2090 ,(2013) , 10.1016/S0140-6736(13)61127-7

Miguel Ángel Hernán, Babette Brumback, James M. Robins, Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. ,vol. 11, pp. 561- 570 ,(2000) , 10.1097/00001648-200009000-00012

Jill L. Schwartz, Wes Rountree, Angela D. M. Kashuba, Vivian Brache, Mitchell D. Creinin, Alfred Poindexter, Brian P. Kearney, A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel PLoS ONE. ,vol. 6, pp. e25974- ,(2011) , 10.1371/JOURNAL.PONE.0025974

Supriya D. Mehta, Stephen Moses, Corette B. Parker, Kawango Agot, Ian Maclean, Robert C. Bailey, Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection AIDS. ,vol. 26, pp. 1141- 1149 ,(2012) , 10.1097/QAD.0B013E328352D116

Christine Johnston, David M. Koelle, Anna Wald, Current status and prospects for development of an HSV vaccine Vaccine. ,vol. 32, pp. 1553- 1560 ,(2014) , 10.1016/J.VACCINE.2013.08.066

Helen A Weiss, Judith R Glynn, Pamela L Cross, James A Whitworth, Richard J Hayes, Esther E Freeman, Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. ,vol. 20, pp. 73- 83 ,(2006) , 10.1097/01.AIDS.0000198081.09337.A7

Darrell Tan, Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females. International Journal of Women's Health. ,vol. 4, pp. 341- 350 ,(2012) , 10.2147/IJWH.S27601